PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
Authors
Keywords
-
Journal
PROSTATE CANCER AND PROSTATIC DISEASES
Volume 19, Issue 3, Pages 223-230
Publisher
Springer Nature
Online
2016-05-03
DOI
10.1038/pcan.2016.13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PSMA-Based Detection of Prostate Cancer Bone Lesions With 18 F-DCFPyL PET/CT: A Sensitive Alternative to 99m Tc-MDP Bone Scan and Na 18 F PET/CT?
- (2016) Steven P. Rowe et al. Clinical Genitourinary Cancer
- Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
- (2016) Lars Budäus et al. EUROPEAN UROLOGY
- Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
- (2016) Tobias Maurer et al. JOURNAL OF UROLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
- (2015) D. E. Spratt et al. CANCER RESEARCH
- A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
- (2015) N. Pandit-Taskar et al. CLINICAL CANCER RESEARCH
- 68Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer
- (2015) Riccardo Schiavina et al. Clinical Genitourinary Cancer
- PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
- (2015) Frederik L. Giesel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
- (2015) Tobias Maurer et al. EUROPEAN UROLOGY
- Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
- (2015) Malcolm D. Mason et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
- (2015) S. P. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
- (2015) M. Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naive and Castration-Resistant Metastatic Prostate Cancer
- (2015) S. P. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
- (2015) J. J. Morigi et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
- (2015) M. Weineisen et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
- (2015) Markus Dietlein et al. MOLECULAR IMAGING AND BIOLOGY
- Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
- (2015) Zsolt Szabo et al. MOLECULAR IMAGING AND BIOLOGY
- Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting
- (2015) Andrea K. Miyahira et al. PROSTATE
- Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by68Ga-PSMA-positron emission tomography/computerized tomography
- (2015) S. Hijazi et al. PROSTATE
- The biology and treatment of oligometastatic cancer
- (2015) Diane K. Reyes et al. Oncotarget
- The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
- (2014) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer
- (2014) S. Vallabhajosula et al. JOURNAL OF NUCLEAR MEDICINE
- Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
- (2014) Nerissa Therese Viola-Villegas et al. MOLECULAR PHARMACEUTICS
- Phase II Study of Lutetium-177-Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer
- (2013) S. T. Tagawa et al. CLINICAL CANCER RESEARCH
- Erratum to: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2013) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biochemical Response to Androgen Deprivation Therapy Before External Beam Radiation Therapy Predicts Long-term Prostate Cancer Survival Outcomes
- (2013) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
- (2013) Joseph R. Osborne et al. JOURNAL OF UROLOGY
- A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult
- (2013) J. F. Goodwin et al. Cancer Discovery
- Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
- (2013) W. R. Polkinghorn et al. Cancer Discovery
- Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography
- (2012) Alejandro Sanchez-Crespo APPLIED RADIATION AND ISOTOPES
- PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era
- (2012) Sean E. McGuire et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- (2012) S. Y. Cho et al. JOURNAL OF NUCLEAR MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection
- (2011) Alberto Briganti et al. EUROPEAN UROLOGY
- 123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy
- (2011) S. M. Hillier et al. JOURNAL OF NUCLEAR MEDICINE
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
- (2010) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
- (2010) J. P. Holland et al. JOURNAL OF NUCLEAR MEDICINE
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
- (2010) Michel Bolla et al. LANCET ONCOLOGY
- Is Biochemical Response More Important Than Duration of Neoadjuvant Hormone Therapy Before Radiotherapy for Clinically Localized Prostate Cancer? An Analysis of the 3- Versus 8-Month Randomized Trial
- (2009) Abraham Alexander et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preliminary Results for Characterization of Pelvic Lymph Nodes in Patients With Prostate Cancer by Diffusion-Weighted MR-Imaging
- (2009) Matthias Eiber et al. INVESTIGATIVE RADIOLOGY
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
- (2008) R. C. Mease et al. CLINICAL CANCER RESEARCH
- The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis
- (2008) A.M. Hövels et al. CLINICAL RADIOLOGY
- Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy
- (2008) Bruce J. Trock JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
- (2008) Eric M. Horwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
- (2008) Anders Widmark et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started